Omikron has now been identified in 57 countries, and although more data is needed on the risks of the variant and its ability to evade vaccine immunity, the World Health Organization is now warning of future impacts on health care systems.
“Although its risk is equal to or likely to be less than that of a delta variable, hospitalizations are expected to increase if more people become infected, and there will be a time gap between an increase in infection and an increase in deaths,” the World Health Organization said on Tuesday.
The number of micron cases doubled From the week ending December 5, the number of cases rose to more than 62,000, and “very significant” increases in cases were also observed in Eswatini (formerly Swaziland), Zimbabwe, Mozambique, Namibia and Lesotho, according to the World Health Organization.
Preliminary analyzes show that mutations in the omicron risk increased re-infection, as the natural immune system was reduced after infection.
If immunity to the vaccine also decreases More study is needed, according to the World Health Organization, but an early study conducted at the African Research Institute in Durban shows that there was a sharp decrease in antibodies in the omicron immune response to people who received two injections of Pfizer’s Coronavina vaccine.
The level of neutralizing antibodies is said to be 40 times lower than the variant detected in China two years ago, and thus it is assumed that omicron partially bypasses the immune system.
According to the study, the vaccine may still offer some protection.
“Unapologetic writer. Bacon enthusiast. Introvert. Evil troublemaker. Friend of animals everywhere.”